Scalp Crusts: Causes, Symptoms, and When to See a Doctor

What Are Scalp Crusts?

Scalp crusts are not, in themselves, a disease. They are a symptom: a visible manifestation of an underlying process affecting the scalp skin. Understanding this distinction is clinically important: treating the crusts without identifying and managing their cause is analogous to turning off a warning light without fixing the engine.

Crusts form when the normal surface of the scalp skin is disrupted, most commonly through one of three mechanisms:

1. Desquamation and scaling: Accelerated or abnormal shedding of scalp skin cells, as in seborrheic dermatitis or psoriasis, produces accumulations of dead skin that form visible scales and crusts.
2. Exudate formation and drying: Inflammatory processes, infections, or wounds produce serous, purulent, or hemorrhagic exudate (fluid) that dries on the scalp surface to form crusts.
3. Blister formation and evolution: Vesicular (blister-forming) conditions, including varicella, herpes zoster, and dermatitis herpetiformis, progress through a predictable sequence: vesicle formation → rupture → crusting.

The nature, appearance, location, and associated symptoms of scalp crusts vary significantly depending on the underlying cause, which is precisely why clinical evaluation is necessary for accurate diagnosis and effective treatment.

---

Causes of Scalp Crusts

The spectrum of conditions capable of producing scalp crusts is broad. The following section covers the most clinically important causes in order of relative frequency.

Seborrheic Dermatitis

Seborrheic dermatitis is the most common cause of scalp crusting in adults, and one of the most prevalent skin conditions overall. It is a chronic, relapsing inflammatory dermatosis that affects areas of the body with the highest density of sebaceous (oil-producing) glands, particularly the scalp, face (especially the eyebrows, nasolabial folds, and around the nose), ears, upper chest, and back.

Pathophysiology

Despite decades of research, the precise cause of seborrheic dermatitis remains incompletely understood. Current evidence points to a combination of three interacting factors:

1. Sebaceous gland activity and sebum overproduction: Excess sebum creates a lipid-rich environment on the skin surface.
2. Malassezia yeast colonization: Malassezia species, particularly M. globosa* and M. restricta are lipophilic yeasts naturally present on human skin. In susceptible individuals, they metabolize sebum lipids into free fatty acids that irritate and inflame the skin, triggering the characteristic scaling and desquamation.
3. Host immune response: Seborrheic dermatitis appears to involve an aberrant inflammatory response to Malassezia colonization in genetically predisposed individuals.

Clinical Features

Characteristic signs and symptoms include:

• Scaling: The hallmark feature. Scales may be white and dry (resembling classic dandruff) or yellowish, greasy, and adherent (particularly on the scalp), forming visible crusts and flakes in the hair and on clothing.
• Erythema (redness) of the affected skin
• Itching (pruritus): Often moderate; scratching worsens scaling and risks secondary bacterial infection
• Oily, shiny-appearing skin in affected areas

Clinical Course and Management

Seborrheic dermatitis is a chronic condition; it cannot be permanently cured, but it can be effectively controlled with appropriate treatment. Flares are commonly triggered by stress, fatigue, cold and dry weather, hormonal changes, and certain medications (including lithium and some neurological drugs). Notably, seborrheic dermatitis is significantly more prevalent in patients with Parkinson’s disease.

Treatment options include:

• Medicated shampoos containing antifungal agents (such as ketoconazole, zinc pyrithione, selenium sulfide, and ciclopirox) are the cornerstone of scalp management.
• Topical antifungals: Ketoconazole or ciclopirox cream for facial involvement.
• Topical corticosteroids: For acute inflammatory flares; short-course use to avoid atrophy and rebound.
• Calcineurin inhibitors (tacrolimus, pimecrolimus): Effective non-steroidal anti-inflammatory options suitable for longer-term use.
• Lifestyle measures: Stress management, avoiding harsh hair products, and regular shampooing.

Cradle Cap

Cradle cap (seborrhoeic capitis neonatorum) is the infantile equivalent of seborrheic dermatitis, a self-limiting, transient form of seborrheic dermatitis that affects the scalp of infants, typically in the first weeks to months of life.

It presents as greasy, yellowish or brownish scales and crusts on the scalp, which may extend to the forehead, eyebrows, and behind the ears. Despite its dramatic appearance, cradle cap is harmless, does not cause the infant discomfort (it is not itchy), and resolves spontaneously in most cases within weeks to months.

Management involves gentle regular washing with a mild baby shampoo and, when needed, careful softening and removal of scales using emollient oils (such as olive oil or baby oil) before washing. Medical treatment with low-potency topical antifungals is occasionally warranted for persistent cases.

Scalp Psoriasis

Psoriasis is a chronic, immune-mediated inflammatory skin disease affecting approximately 2–3% of the global population. Scalp involvement is extremely common, present in approximately 80% of psoriasis patients at some point during their disease, and is frequently the first or only site of disease in a significant proportion of patients.

Pathophysiology

Psoriasis is driven by an aberrant T-cell-mediated immune response that massively accelerates epidermal cell turnover. Normally, skin cells complete their full maturation cycle in approximately 28 days; in psoriasis, this process is compressed to 3–4 days. The resulting accumulation of immature, rapidly produced keratinocytes forms the characteristic thick, silvery-white plaques.

Clinical Features

Scalp psoriasis typically presents as:

• Well-demarcated, erythematous (red) plaques covered with thick, silvery-white scales, the most recognizable hallmark
• Plaques that may extend beyond the hairline onto the forehead, behind the ears, or to the nape of the neck
• Pruritus (itching): Often significant and distressing; scratching worsens the plaques and can introduce secondary infection
• Temporary hair loss: Traction from thick crusts and scratching can cause mechanical alopecia, though this is generally reversible with treatment
• The “Auspitz sign”: When scales are removed, pinpoint bleeding is typically revealed, which is a characteristic finding in psoriasis

Triggers and Clinical Course

Psoriasis follows a relapsing-remitting pattern, with periods of flare and relative remission. Known triggers include:

• Stress and psychological factors
• Fatigue
• Dry skin
• Infections (particularly streptococcal throat infection)
• Certain medications (lithium, beta-blockers, NSAIDs, antimalarials)
• Alcohol and smoking

Treatment

Management includes:

• Medicated shampoos: Coal tar, salicylic acid (a keratolytic that helps remove scale), and corticosteroid-based formulations
• Topical corticosteroids: The most widely used treatment for scalp psoriasis
• Vitamin D analogues (calcipotriol, calcitriol): Slow epidermal cell proliferation
• Systemic treatments for moderate-to-severe disease: methotrexate, ciclosporin, acitretin
• Biological therapies: TNF-alpha inhibitors, IL-17 inhibitors, IL-23 inhibitors, which are highly effective for refractory disease

Eczema and Atopic Dermatitis

Eczema is an umbrella term for a group of inflammatory skin conditions characterized by dry, itchy, inflamed skin. The most common form, atopic dermatitis, is a chronic condition with a strong genetic component. It typically begins in infancy or early childhood and is frequently associated with other atopic diseases, such as allergic rhinitis, asthma, and food allergies.

When atopic dermatitis affects the scalp, it produces:

• Dryness and scaling: The compromised skin barrier function leads to excessive water loss and a characteristic dry, flaky scalp
• Intense pruritus: Scratching is the defining behavior and the most destructive one. The itch-scratch cycle perpetuates and worsens the condition: scratching damages the skin, increases inflammation, and intensifies itching
• Erythema and weeping: Acutely inflamed areas may become red, swollen, and produce clear fluid (serous exudate) that dries to form crusts
• Lichenification: With chronic scratching, the skin thickens and takes on a leathery texture

Management involves:

• Daily emollient application: Essential for restoring and maintaining the compromised skin barrier, which is the foundation of all atopic dermatitis treatment
• Topical corticosteroids: For flare management
• Topical calcineurin inhibitors: Particularly useful for long-term maintenance and sensitive areas
• Systemic immunosuppressants: For moderate-to-severe disease, dupilumab (a biologic targeting IL-4 and IL-13) has transformed the treatment landscape for atopic dermatitis.
• Phototherapy: For refractory cases

Dermatitis Herpetiformis

Dermatitis herpetiformis (DH) is a chronic, intensely pruritic autoimmune blistering condition that is the cutaneous manifestation of celiac disease. It affects primarily adults and is driven by IgA antibody deposition in the dermis in response to gluten ingestion.

Typical presentation includes:

• Intensely itchy papules and vesicles (small blisters) on a symmetrical distribution affecting elbows, knees, buttocks, back, and, in a significant proportion of patients, the scalp
• Burning sensation that may precede visible lesion formation
• When vesicles rupture or are scratched, they evolve into characteristic crusts

The connection to celiac disease is critical: the only disease-modifying treatment is a strict, lifelong gluten-free diet. Dapsone, a sulfonamide antibiotic traditionally used in leprosy, provides rapid symptomatic relief and is used as an adjunct during the months required for the gluten-free diet to produce its full effect.

Any patient presenting with this characteristic rash pattern should be evaluated for underlying celiac disease, as the gastrointestinal manifestations may be subtle or absent.

Lichen Planus of the Scalp

Lichen planus is a chronic inflammatory condition affecting skin, mucous membranes, nails, and hair follicles. Its cause remains incompletely understood but appears to involve T-cell-mediated immune attack on basal keratinocytes.

When it affects the scalp, a variant known as lichen planopilaris (LPP), the clinical picture is distinctive and particularly serious:

• Inflammatory scalp lesions: Erythema, scaling, and crusting around hair follicles.
• Progressive and irreversible scarring alopecia (hair loss): LPP destroys hair follicles, replacing them with fibrous scar tissue. This hair loss is permanent, a feature that distinguishes LPP from most other scalp conditions and makes early diagnosis and treatment critically important.
• Pruritus, burning, and pain: Patients often describe a combination of itch and pain in affected areas.

Treatment aims to arrest disease progression and manage symptoms:

• Corticosteroids: Topical, intralesional (injected directly into affected areas), or systemic, depending on severity.
• Antihistamines: For symptom management
• Immunomodulatory agents: Hydroxychloroquine, cyclosporin, mycophenolate mofetil for progressive disease

Given the risk of permanent hair loss, any patient with suspected LPP should be referred to a dermatologist without delay.

Scratch-Induced Excoriations

Any condition causing significant scalp itching can lead to crusting as a direct consequence of scratching, regardless of the primary cause of the itch. The most clinically important itch-producing conditions of the scalp include:

Irritant Contact Dermatitis

Irritant contact dermatitis of the scalp occurs when a chemical substance directly damages the skin surface through a non-allergic mechanism. Common scalp irritants include harsh shampoos and conditioners, hair dyes (the dye base rather than the specific allergens), bleaching agents, relaxers, and chemical straighteners. The result is erythema, scaling, and itching, with secondary crusting from scratching.

Allergic Contact Dermatitis

Allergic contact dermatitis of the scalp involves a true Type IV (delayed) hypersensitivity reaction to a specific allergen. The most clinically significant scalp allergen is paraphenylenediamine (PPD), the principal coloring agent in most commercial permanent hair dyes. Other important allergens include fragrances and preservatives in hair products, and nickel in hair accessories.

The reaction typically develops 24 to 72 hours after exposure, producing an intensely itchy, erythematous, scaling, or vesicular rash that, when scratched, progresses to crusting. Severe reactions can cause marked scalp edema and involve the face and neck. Patch testing is required to identify the responsible allergen.

Head Lice (Pediculosis Capitis)

Head lice (Pediculus humanus capitis) are small, obligate human ectoparasites that infest the scalp and feed on blood. Infestation is extremely common, particularly in school-age children, and spreads primarily through direct head-to-head contact.

The primary symptom is intense scalp itching (caused by an allergic reaction to louse saliva), which drives scratching and leads to excoriations and secondary crusting. Diagnosis is confirmed by finding live lice or viable nits (eggs, firmly cemented to hair shafts) under careful visual inspection. Treatment involves topical insecticide preparations (permethrin, malathion, or newer agents such as dimeticone) combined with mechanical removal using a fine-toothed nit comb.

Neuropathic Pruritus

Scalp itching without visible skin disease, known as neuropathic pruritus, may occur due to abnormal signaling in cutaneous nerve fibers or central pain processing pathways. One recognized entity is brachioradial pruritus (itching of the lateral arms and scalp), associated with cervical spine pathology. Senile pruritus in older adults also has a significant neuropathic component. Scratching driven by neuropathic itch predictably produces excoriations and secondary crusting.

Insect Bites

Insect bites on the scalp from mosquitoes, fleas, or other biting insects cause localized wheals and intense pruritus. Scratching leads to excoriation and crusting. Multiple bites in a linear pattern or scattered distribution should raise suspicion for infestation (fleas, mites).

Scalp Infections

Infectious processes capable of producing scalp vesicles, ulcerations, or inflammatory lesions are an important and clinically distinct category of scalp crusting.

Impetigo

Impetigo is a highly contagious superficial bacterial skin infection caused most commonly by Staphylococcus aureus and/or Streptococcus pyogenes. While it most frequently affects the face and limbs, the scalp can also be involved, particularly as a superinfection of pre-existing abrasions, insect bites, or areas damaged by scratching.

The characteristic progression is:

• Initial red papules or pustules that may resemble pimples
• Evolution into fragile blisters (bullae in bullous impetigo)
• Rupture of blisters with formation of the pathognomonic honey-colored (golden-yellow) adherent crusts

Impetigo is treated with topical antibiotics (mupirocin or fusidic acid) for localized disease, or oral antibiotics (flucloxacillin, cefalexin) for more extensive involvement. It is highly contagious and children with active impetigo should be excluded from school until lesions are crusted over and treatment has been initiated.

Tinea Capitis (Scalp Ringworm)

Tinea capitis is a dermatophyte fungal infection of the scalp, affecting the hair shaft and follicle. It is predominantly a condition of childhood but can affect adults. Transmission occurs through direct contact with infected individuals, animals, or fomites (combs, brushes, hats, pillowcases).

Clinical features include:

• Pruritus and scaling often resemble seborrheic dermatitis or dandruff in early stages.
• Patchy alopecia: Characteristic round or oval patches of hair loss, typically with broken hairs (“black dots”) visible at the follicle openings.
• Erythema and crusting: The inflamed scalp surface may produce adherent crusts.
• Kerion: A severe inflammatory variant where the scalp develops a painful, boggy, pustular swelling, representing an intense immune response to the dermatophyte. This requires systemic antifungal treatment.

Diagnosis can be confirmed by scalp scraping and hair plucking for mycological examination. Topical antifungals alone are insufficient; systemic antifungal therapy (such as griseofulvin, terbinafine, or itraconazole) is required for effective treatment.

Varicella (Chickenpox) and Herpes Zoster (Shingles)

Both conditions are caused by varicella-zoster virus (VZV):

• Varicella (chickenpox): Primary infection with VZV produces the characteristic widespread vesicular rash that covers the entire body, including the scalp, which is frequently one of the first areas to develop lesions. Vesicles progress through the characteristic sequence: clear vesicle → cloudy pustule → crusting → healing. Scalp lesions are intensely itchy.

• Herpes zoster (shingles): Reactivation of latent VZV in a dorsal root or cranial nerve ganglion, producing a dermatomal distribution of painful vesicles. This means the rash is confined to the area of skin supplied by the affected nerve root. When the ophthalmic branch of the trigeminal nerve is involved (herpes zoster ophthalmicus), scalp lesions may appear on the forehead and scalp along with potentially serious eye involvement. Herpes zoster on the scalp is less common than at thoracic sites but does occur. Unlike varicella’s widespread distribution, zoster’s strictly unilateral, dermatomal pattern is diagnostically distinctive.

Other and Rarer Causes

Additional conditions that may produce scalp crusting, though less commonly encountered, include:

• Eosinophilic folliculitis: A rare inflammatory disorder of the hair follicles causing pruritic papules and pustules, seen primarily in immunocompromised individuals (including those with HIV/AIDS).
• Folliculitis decalvans: A rare chronic neutrophilic folliculitis causing progressive, painful scalp inflammation, suppuration, and irreversible scarring alopecia, similar to lichen planopilaris.
• Trauma: Any significant scalp injury, such as a laceration, abrasion, or surgical wound, will produce crusting during the normal healing process. The management depends on the wound depth and any complications.

---

When Scalp Crusting Requires Urgent Evaluation

Several scenarios warrant prompt medical assessment rather than watchful waiting:

• A single non-healing ulcer or growth: The development of a solitary lesion that enlarges, bleeds, or fails to heal over several weeks should always prompt medical evaluation to exclude malignancy, including basal cell carcinoma, squamous cell carcinoma, or (less commonly) melanoma, which can all occur on the scalp. The scalp is a sun-exposed area frequently overlooked in skin cancer screening.

• Signs of scarring alopecia: Persistent patchy hair loss with scalp inflammation and crusting, especially if the hair loss is expanding, suggests lichen planopilaris or other scarring alopecia. Early treatment is critical in these cases to prevent irreversible follicle destruction.

• Systemic symptoms: Fever, lymphadenopathy (swollen glands), generalized rash, joint pain, eye involvement, or other systemic features alongside scalp crusting may indicate a systemic autoimmune or infectious condition.

• Rapidly spreading or worsening infection: Signs of spreading cellulitis (warm, red, rapidly expanding skin infection), kerion, or impetigo involving a large scalp area require prompt medical management.

• Any crusting that does not respond to 2–4 weeks of appropriate self-care: Persistent or worsening scalp crusting despite gentle hair care and moisturizing warrants dermatological evaluation.

---

Treatment and Remedies: Why Diagnosis Comes First

Among the most commonly recommended online “remedies” for scalp crusts are natural products such as aloe vera, tea tree oil, and omega-3 fatty acids. While some of these have modest biological plausibility for specific conditions, there is a critical problem with recommending them generically: without a precise diagnosis, they are unlikely to be effective and may occasionally be counterproductive.

Consider the following scenarios:

• Tea tree oil on a fungal infection (tinea capitis): While tea tree oil has in vitro antifungal activity, it has not been shown to achieve the follicular penetration required to eradicate a dermatophyte scalp infection. Using it instead of appropriate systemic antifungal therapy delays effective treatment and risks disease progression and irreversible hair loss.
• Aloe vera on psoriasis: While soothing, aloe vera does not address the immune-mediated mechanism of psoriasis. Relying on it while disease activity continues means ongoing follicular damage.
• Any natural product applied to an active bacterial infection: May delay antibiotic treatment of impetigo, a highly contagious infection that, while rarely serious, can spread to others and is easily treated with appropriate antibiotics.
• Natural products on lichen planopilaris: Every week without specific anti-inflammatory treatment is a week during which irreversible scarring is occurring.

The time lost to trial-and-error with unproven remedies can make a meaningful clinical difference, particularly in conditions where early treatment prevents permanent damage.

The Appropriate Approach

1. See a doctor or dermatologist for assessment of persistent, concerning, or worsening scalp crusting. A brief clinical examination, supplemented where necessary by dermatoscopy, scalp scraping for mycology, patch testing, or biopsy, can provide a precise diagnosis in the vast majority of cases.

2. Use the diagnosis to guide treatment: Each condition has specific, evidence-based treatment options (as detailed in the sections above). Targeted treatment is almost always more effective than empirical natural remedies.

3. In the meantime: Use a gentle, fragrance-free shampoo and avoid aggressive hair care products, heat styling, and scratching. A gentle emollient (fragrance-free moisturizing cream or scalp oil) can provide comfort without risking irritation of the underlying condition.

4. Do not scratch: Scratching perpetuates scalp damage, worsens inflammation, risks secondary bacterial infection, and in scarring conditions, accelerates irreversible hair follicle destruction.

---

Bibliography and Sources

• Borda, L.J., & Wikramanayake, T.C. (2015). Seborrheic dermatitis and dandruff: a comprehensive review. Journal of Clinical and Investigative Dermatology, 3(2), 10.13188/2373-1044.1000019.

• Schwartz, R.A., Janusz, C.A., & Janniger, C.K. (2006). Seborrheic dermatitis: an overview. American Family Physician, 74(1), 125–130.

• Menter, A., Korman, N.J., Elmets, C.A., et al. (2009). Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. Journal of the American Academy of Dermatology, 60(4), 643–659.

• Eichenfield, L.F., Tom, W.L., Berger, T.G., et al. (2014). Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies. Journal of the American Academy of Dermatology, 71(1), 116–132.

• Antiga, E., & Caproni, M. (2015). The diagnosis and treatment of dermatitis herpetiformis. Clinical, Cosmetic and Investigational Dermatology, 8, 257–265.

• Wolff, K., Goldsmith, L.A., Katz, S.I., Gilchrest, B.A., Paller, A.S., & Leffell, D.J. (Eds.). Fitzpatrick’s Dermatology in General Medicine (8th ed.). McGraw-Hill.

• Fuller, L.C., Barton, R.C., Mohd Mustapa, M.F., Seed, P.T., Pumphrey, R.S., & Cressey, P.J. (2014). British Association of Dermatologists’ guidelines for the management of tinea capitis 2014. British Journal of Dermatology, 171(3), 454–463.

• Mortz, C.G., & Andersen, K.E. (2010). Allergic contact dermatitis in children and adolescents. Contact Dermatitis, 63(1), 1–11.

• Harries, M., & Sinclair, R. (2014). Lichen planopilaris. Clinical, Cosmetic and Investigational Dermatology, 7, 261–271.

• Mirmirani, P. (2013). Managing hair loss in midlife women. Maturitas, 74(2), 119–122.